Diltiazem + Bosentan Interaction
Majorinteraction on record
Description
Moderate CYP3A inhibitor; when combined with a CYP2C9 inhibitor, will likely lead to large increases in bosentan plasma concentrations. Co-administration not recommended.
Mechanism
CYP3A inhibition
Source: NLP:bosentan